Rebecca T. Hahn, MD

Cardiovascular Disease
Accepting New Patients
Profile Headshot


Dr. Hahn is Professor of Medicine at Columbia University Irving Medical Center, Chief Scientific Officer of the Echo Core Lab at the Cardiovascular Research Foundation and Director of Interventional Echocardiography at the Columbia Structural Heart & Valve Center.  Dr. Hahn attended Washington University School of Medicine in St. Louis and completed her residency in internal medicine, fellowship in cardiology, and research fellowship in cardiology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

She is an active member of the American Society of Echocardiography as well as the American College of Cardiology (member of the Competency Management Committee, past Scientific Sessions Planning Committee/Valvular Heart Disease Topic Coordinator). She has published over 250 articles on Echocardiography and Valvular Heart Disease.  She has co-authored the following American Society of Echocardiography recommendations/guidelines:  “Guidelines for Performing a Comprehensive Transesophageal Echocardiographic Examination"; "Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation"; "Guidelines for the Evaluation of Valvular Regurgitation After Percutaneous Valve Repair or Replacement" and “Guidelines for the Use of Transesophageal Echocardiography to Assist with Surgical Decision-Making in the Operating Room”; and “Recommended Standards for the Performance of Transesophageal Echocardiographic Screening for Structural Heart Intervention”. 

Dr. Hahn participates on the following Academic Research Consortium writing committees: Valve Academic Research Consortium (VARC-3), Paravalvular Leak Academic Research Consortium, Mitral Valve Academic Research Consortium and Tricuspid Valve Academic Research Consortium.   She was National PI for the SCOUT Trial and is the National Co-PI for the Triscend Pivotal Trial. 

Areas of Expertise / Conditions Treated

  • Echocardiography
  • Percutaneous Valve Interventions
  • TAVR (Transcatheter Aortic Valve Replacement)
  • Transesophageal Echocardiography
  • Valve Reconstruction/Repair
  • Valve Replacement
  • Valvular Heart Disease

Academic Appointments

  • Professor of Medicine at CUMC

Administrative Titles

  • Director of Interventional Echocardiography

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center


  • Female

Schedule an Appointment

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In


161 Fort Washington Avenue
New York, NY 10032

Insurance Accepted


  • Medicare Managed Care
  • Special Needs

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • University of Washington School of Medicine
  • Residency: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Weill Cornell Medical Center

Board Certifications

  • Cardiovascular Disease
  • Internal Medicine


Selected Publications

Echocardiographic Imaging of Procedural Complications During Self-Expandable Transcatheter Aortic Valve Replacement.
Hahn RT1, Gillam LD2, Little SH3.

Echocardiographic Imaging of Procedural Complications During Balloon-Expandable Transcatheter Aortic Valve Replacement.
Hahn RT1, Kodali S2, Tuzcu EM3, Leon MB2, Kapadia S3, Gopal D4, Lerakis S5, Lindman BR6, Wang Z7, Webb J8, Thourani VH5, Douglas PS9.

Recommendations for Comprehensive Intraprocedural Echocardiographic Imaging During TAVR.
Hahn RT1, Little SH2, Monaghan MJ3, Kodali SK4, Williams M5, Leon MB4, Gillam LD6.

Assessment of paravalvular aortic regurgitation after transcatheter aortic valve replacement: intra-core laboratory variability.
Hahn RT1, Pibarot P2, Weissman NJ3, Rodriguez L4, Jaber WA4.

Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve).
Hahn RT1, et. al.

Downregulation of the glucocorticoid-induced leucine zipper (GILZ) promotes vascular inflammation.
Hahn RT1, Hoppstadter J1, Hirschfelder K1, Hachenthal N1, Diesel B1, Kessler SM1, Huwer H2, Kiemer AK3.

Paravalvular regurgitation following transcutaneous aortic valve replacement: predictors and clinical significance.
Hahn RT, Kodali S, Genereux P, Leon M.

Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists.
Hahn RT1, Abraham T, Adams MS, Bruce CJ, Glas KE, Lang RM, Reeves ST, Shanewise JS, Siu SC, Stewart W, Picard MH; American Society of Echocardiography; Society of Cardiovascular Anesthesiologists.

Guidance of transcatheter aortic valve replacement by echocardiography.
Hahn RT1.

Predicting paravalvular regurgitation following transcatheter valve replacement: utility of a novel method for three-dimensional echocardiographic measurements of the aortic annulus.
Hahn RT1, Khalique O, Williams MR, Koss E, Paradis JM, Daneault B, Kirtane AJ, George I, Leon MB, Kodali S.

Use of imaging for procedural guidance during transcatheter aortic valve replacement.
Hahn RT1.

Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves).Com
Hahn RT1, et. al

Should echocardiographers embrace the FOCUS examination?
Hahn RT.